Lisa is the inaugural Director of Medical Oncology and acting Director of Research at the Chris O'Brien Lifehouse. She has an active clinical practice and is involved with a large number of clinical trials in prostate and colorectal cancers in addition to phase I trial work.
Background:
Having completed medical school at the University of Sydney and
trained in medical oncology at Royal Prince Alfred Hospital Lisa
subsequently worked at the Garvan Institute completing her PhD in
translational research in 2004. Lisa was appointed to the senior
staff of Royal Prince Alfred Hospital in 2003 andn has been a
visiting scientist at the Garvan Institute for Medical Research for
13 years and is the Head of Prostate Cancer Therapeutics at The
Kinghorn Cancer Centre.
To unwind at the end of the day Lisa likes to
read a good book
Research Interests:
Since returning to clinical practice, Lisa's research has
focused on drug resistance in castrate-resistant prostate cancer.
This work integrates clinical trial work and correlative biomarker
studies using both standard and experimental anti-cancer
treatments. While mainly a prostate cancer researcher, she has also
applied this paradigm to lung and colorectal cancer research.